Cargando…
LGL leukemia patients exhibit substantial protective humoral responses following SARS‐CoV‐2 vaccination
Large granular lymphocyte leukemia is a rare chronic lymphoproliferative disorder of cytotoxic cells. Other hematological malignancies such as CLL and multiple myeloma have been associated with poor vaccination response and markedly increased severe acute respiratory syndrome coronavirus 2 (SARS‐CoV...
Autores principales: | Cheon, Heejin, Elghawy, Omar, Shemo, Bryna C., Feith, David J., Loughran, Thomas P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348025/ https://www.ncbi.nlm.nih.gov/pubmed/35941882 http://dx.doi.org/10.1002/jha2.472 |
Ejemplares similares
-
Emergence of a STAT3 mutated NK clone in LGL leukemia
por: Yan, Yiyi, et al.
Publicado: (2014) -
Retrovirus insertion site analysis of LGL leukemia patient genomes
por: Li, Weiling, et al.
Publicado: (2019) -
Cyclophosphamide as a first-line therapy in LGL leukemia
por: Moignet, A, et al.
Publicado: (2014) -
A case of LGL leukemia with paucity of erythropoiesis
por: Razavi, Habib M.
Publicado: (2020) -
A guilt-by-association mutation network in LGL leukemia
por: Andersson, Emma I., et al.
Publicado: (2017)